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ABSTRACT 
Chitosan has been extensively used to prepare hydrogel systems. The fact that chemically and ionically crosslinked chitosan hydrogels can slowly 
release drugs through swelling have enabled their use in drug delivery applications. In addition, the high porosity of these hydrogels ensures a more 
effective cell loading and depending on the pore size and interconnectivity, it can lead to cell differentiation and eventually tissue formation. The 
purpose of this review is to take a closer look at the use of chitosan hydrogels to prepare drug delivery systems and scaffolds for tissue engineering. 
Aspects involving chitosan structure, physicochemical properties and biological applications are also discussed. In addition, this article reviews the 
methods used to prepare chitosan hydrogels and the mechanisms involved in the release of drugs. 
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INTRODUCTION 
Chitosan has been extensively used to synthesize hydrogels due to 
its good crosslinking ability, which has been attributed to the 
presence of free amine groups in its backbone [1]. In addition, its 
biodegradability, biocompatibility and non-toxicity make chitosan 
hydrogels very attractive for biomedical applications [2-4]. Chitosan 
hydrogels have been prepared as microspheres [5, 6], nanospheres 
[7], beads[8-10], sponges [11], wound dressings [12], films [13] and 
scaffolds for tissue engineering [14-16]. 
Chitosan hydrogels can be categorized in two different classes 
depending on the nature of their network, namely physical or 
chemical hydrogels, with the latter being prepared through chemical 
crosslinking, which seems to be the best approach to improve the 
wet strength of these hydrogels [17]. Chemical hydrogels are usually 
prepared through interchain interaction between chitosan’s free 
amine groups, which is achieved by using a crosslinking agent [2, 18] 
such as formaldehyde [1] and glutaraldehyde [19-21]. It has been 
shown that variables such as gelation time, mechanical strength, 
network pore size, degradation time, degree of swelling and the rate 
of drug release can be controlled by the extent of chemical 
crosslinking [22, 23]. 
In addition, chitosan hydrogels can swell and uptake a large amount 
of water, which has been attributed to its highly porous structure. 
The degree of porosity can be modulated by the polymer 
concentration as well as by the degree of crosslinking [22, 24]. Thus, 
the porosity of the hydrogel can have a direct impact on the drug 
release and cell ingrowth (tissue formation), where the latter 
represents a fundamental requirement for the success of a scaffold 
for tissue engineering [3, 21]. 
Polymer scaffolds have been used for tissue engineering applications 
as they serve to support, reinforce and organize the regenerating 
tissue [17, 25]. In fact, scaffolds prepared from chitosan hydrogels 
have become attractive for tissue engineering applications for 
repairing and regenerating a wide variety of tissues and organs, 
where the presence of interconnecting pores, the optimal pore size 
and shape and the biocompatibility/ biodegradability aspect 
represent the most important properties in order to ensure the 
supply of the cells with nutrients and favor tissue integration and 
vascularization [19, 21, 26]. 
Physicochemical properties and biomedical applications of 
chitosan  
Chitosan is a linear copolymer of β(1→4) linked 2-acetamido-2-
deoxy-β-D-glucopyranose and 2-amino-2-deoxy-β-D-glycopyranose 
(fig. 1). It is easily obtained through the deacetylation of chitin; the 
second most abundant polysaccharide found in nature as a 
component of exoskeletons of crustaceans and insects [27-29]. 
Chitin and chitosan are structurally similar to cellulose, except for an 
acetamido or amine group at C-2 instead of a hydroxyl group 
(cellulose) at this position [30]. 
 
 
Fig. 1: Representation of chitosan’s structure with x and y 
values varying according to the degree of deacetylation, each 
carbon is appropriately numbered, where the amine or 
acetamido group at C2 represents the deacetylated and 
acetylated fractions, respectively. Source: Author’s own design 
 
Chitin is deacetylated by using a concentrated NaOH solution, as 
shown in fig. 2[31]. This reaction converts the chitin’s acetamido 
group at position C-2 to a free amine group. The pKa
 
 of chitosan 
amine groups is ~6.5 and therefore, it can be solubilized by diluted 
acids through protonation of this groups, rendering the 
corresponding chitosan salt in solution [27]. 
 
Fig. 2: Deacetylation of chitin under NaOH treatment. Note the 
acetyl group from the acetamido being converted to free amine 
group. Source: Author’s own design 
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Since chitosan is converted to a polyelectrolyte in acidic media, its 
positive charges strongly interact with many negatively charged 
cells [31, 32]. In addition, chitosan can bind to cholesterol, fats, 
proteins and tumor cells [30]. Therefore, due to its cationic nature, 
electrostatic complexes have been prepared for encapsulation of 
drugs, immobilization of enzymes and for carrying genes [28]. Since 
these properties are related to the presence of amine groups in 
chitosan glucosamine repeating unit, then it is feasible to consider 
that such properties depends primarily on the degree of 
deacetylation (DD). In fact, it has been shown that the muco and cell 
adhesion properties of chitosan are influenced by its degree of 
deacetylation and cell type as such interactions occur through ionic 
complexation. For instance, fibroblasts exhibit a more negative 
charge surface when compared to keratinocytes, therefore 
exhibiting a higher adhesion to chitosan [33]. Moreover, hydrogels 
prepared from chitosans with different DD (from 65 to 95%), but 
using the same processing conditions, showed that the ones with the 
highest DD provided more elastic hydrogels, with better cell 
adhesion on their surface and more efficient tissue regeneration [4]. 
The cationic groups on chitosan have also been reported to bind to 
anionic groups on microorganisms, resulting in growth inhibition [27, 
34]. For instance, the growth of Escherichia coli, Fusarium, Alternaria and 
Helminthosporium has been inhibited in the presence of chitosan [27]. In 
addition, bactericidal activities against Streptococcus mutans and 
Streptococcus salivarius have been reported [34]. 
Besides the degree of deacetylation, the molecular weight (Mw) of 
chitosan has shown to influence its biological properties, as chitosan 
oligomers of 1 kDa showed higher antimicrobial activity against 
gram-negative bacteria, whereas chitosan oligomers of 4 and 2 kDa 
were more active against gram-positive [35]. The concentration of 
chitosan has also demonstrated to influence its bacteriostatic 
activity, as shown by the minimum concentrations of 0.1 and 1% of 
chitosan solutions that were necessary to inhibit completely S. 
epidermis and S. aureus, respectively [30]. Table 1 lists the main 
biological properties of this biopolymer and their relationship with 
the DD and Mw
 
. 
Table 1: Relationship between chitosan biological properties 




Biodegradability DD, Mw 
Biocompatibility DD 
Mucoadhesion DD, Mw 
Hemostatic DD, Mw 
Analgesic DD 
Adsorption enhancer DD 
Antimicrobial Mw 
Anticholesterolemic DD, Mw 
Antioxidant DD, Mw 
 Source: Author’s own design 
 
As shown in table 1, the DD can also influence the biodegradability 
of chitosan, which is the ability to be enzymatically metabolized, 
particularly by lysozyme. Its biodegradation products are non-toxic 
oligosaccharides of variable length, which can be subsequently 
incorporated into glycosaminoglycans and glycoproteins or into 
other metabolic pathways [33]. This polymer is also biocompatible, 
which has been evidenced by its in vitro cytocompatibility with 
myocardial, endothelial and epithelial cells, as well as with 
fibroblasts, hepatocytes, condrocytes and keratinocytes [28, 33]. 
The DD and Mw can also influence chitosan’s ability to form 
molecular entanglements, which can originate a network structure 
known as hydrogel [25].  
The use of chitosan to prepare hydrogels 
Hydrogel is a three dimensional hydrophilic polymeric network that 
absorb and retain a minimum of 20% of its weight of water or 
biological fluids [1, 22, 36]. This polymeric network is able to retain 
fluids and drastically increase in volume, forming a swollen gel 
phase and depending on the degree of crosslinking and pH, the 
network keeps its three-dimensional (3D) structure and will not 
dissolve [37, 38]. 
Hydrogels are relatively deformable and can conform to the shape of 
the surface to which they are applied [22, 25]. Therefore, hydrogels 
have different physical forms, such as solid molded forms (e. g., soft 
contact lenses), pressed powder matrices (e. g., pills or capsules for 
oral ingestion), microparticles, beads, membranes or sheets (e. g., as 
a reservoir in transdermal drug delivery patch and wound dressing) 
and semi-solid gels [19]. The existence of hydrogels dates back to 
1960, when Wichterle and Lim first proposed the use of hydrophilic 
networks of poly (2-hydroxyethyl methacrylate) (PHEMA) in contact 
lenses [39]. Since then, the use of hydrogels has extended to various 
biomedical and pharmaceutical applications [36, 38]. 
Chitosan has been used to synthesize hydrogels because of its good 
crosslinking ability in addition to its biodegradability, biocompatibility, 
and non-toxicity, which make chitosan hydrogels very attractive for 
use in biomedical and tissue engineering areas [1-4]. 
Types of chitosan hydrogels 
Chitosan hydrogels are categorized in two different classes 
depending on the nature of their network, namely physical or 
chemical hydrogels [18, 25].  
Physical chitosan hydrogels 
Physical chitosan hydrogels are formed by various reversible links 
such as ionic interactions (ionically crosslinked hydrogels), 
secondary interactions (Van der Waals and hydrogen bonds) and 
entangled hydrogels (prepared by solubilization of chitosan in an 
acidic aqueous medium) [18]. Another type of physical chitosan 
hydrogel is the one formed through ionic interaction between 
chitosan and other polymers with negative charges, namely 
polyelectrolyte complex. The electrostatic attraction between the 
protonated amine groups (-NH3+
Yan et al. (2015) prepared physically crosslinked chitosan hydrogels 
by increasing the pH of chitosan solutions above its pKa value 
(~6.5), which has been achieved through homogeneous 
neutralization by ammonia, generated in situ from enzymatic 
hydrolysis of urea. The authors showed that the gelation time could 
be controlled by varying the urea and urease concentrations [17]. 
Similarly, neutralization with sodium hydroxide baths has also been 
used to prepare physical chitosan hydrogels, where a fast gelation 
was attained avoiding the formation of a precipitate [42]. 
) of chitosan and the anionic groups 
of the other polymer is the main interaction that leads to the 
formation of complex polyelectrolyte hydrogels. Since these 
polyelectrolytes represent two oppositely charged polymers, these 
hydrogels have a hydrophilic microenvironment with high water 
content and electrical charge density [18, 40, 41]. However, the main 
drawback of the physical hydrogels formed by polyelectrolyte 
complexation is that both polymers need to be ionized and bear 
opposite charges, which means that the reaction needs to occur at 
pH values in the vicinity of the pKa interval of the two polymers. 
Therefore, the pH of the medium has to be carefully monitored 
during the course of the reaction. Moreover, precipitation of the 
polyelectrolyte complex is quite common if the ionic interaction is 
too strong [25]. 
The main advantage of the physical hydrogel over the covalently 
crosslinked (chemical hydrogels) is that besides chitosan and the 
polyanionic polymer, no additional molecule is necessary, which 
favors biocompatibility and avoids purification before administration 
[18]. However, physical chitosan hydrogels have some limitations. For 
instance, the poor stability of the physical hydrogels can lead to 
disintegration and dissolution when these hydrogels are placed in 
aqueous environment, especially at low pH [1, 22].  
Chemical chitosan hydrogels 
Chemical chitosan hydrogels are prepared by covalent linkages. 
These links are formed through interchain interactions between the 
free amine groups from the various glucosamine units, which are 
achieved through the use of a crosslinking agent (e. g. 
glutaraldehyde). The crosslinking agent is usually introduced in the 
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pre-hydrogel solution and is responsible for avoiding or retarding its 
dissolution/degradation [18]. Therefore, the chemical crosslinking 
seems to be the best approach to improve the wet strength of the 
hydrogels [1]. In addition, another advantage of the chemical 
hydrogels over the physical ones is that variables such as gelation 
time, mechanical strength, network pore size, degradation time, the 
degree of swelling and the rate of drug release can be controlled by 
the extent of crosslinking [22, 43]. However, the disadvantage 
related to this approach is that highly crosslinked hydrogels exhibit 
very limited response to environmental stimuli and may possess 
undesirable mechanical properties. In fact, mechanically strong 
chitosan hydrogels can be obtained as the degree of crosslinking 
increases. However, highly crosslinked hydrogels tend to have poor 
percentage of elongation and therefore, are usually brittle 
structures. Since chitosan hydrogels should maintain its physical 
texture during the delivery of drugs for the predetermined period of 
time, an optimum degree of crosslinking needs to be achieved in 
order to produce a relatively strong and yet elastic hydrogel [43]. 
Crosslinked chitosan networks have been obtained by using 
monoaldehydes (formaldehyde [1]) and di-or polyaldehydes 
(glutaraldehyde [19, 20], oxidized starch [44], oxidized dextran 
[19]and oxidized sugars [45]) as well as genipin [46, 47]. The 
disadvantage of formaldehyde and especially glutaraldehyde is their 
toxicity to human tissues, even at small traces [17, 22, 47]. Although 
glutaraldehyde is still the most commonly used crosslinking agent 
for preparing chitosan hydrogels, the unreacted fraction must be 
completely removed. This procedure becomes critical when 
implantable hydrogels are used as the complete removal of the 
unreacted crosslinking agent has to be done before implantation. 
Thus, the main drawback of such approach is that the removal of the 
crosslinking agent may be difficult to achieve without leaching the 
loaded drugs out of the pre-loaded hydrogel [4, 22].  
On the other hand, oxidized dextran, oxidized starch and genipin 
exhibit minimal toxicity [22]. Pourjavadi et al. [48] designed a new 
hydrogel based on chitosan using a tetra aldehyde molecule as the 
crosslinking agent, obtained from the periodate oxidation of sucrose. 
The hydrogel showed reasonable swelling pH sensitivity, where the 
maximum swelling occurred at low pH (bellow 6.5). Delgadilho-
Armendariz et al. (2014) prepared chitosan hydrogels using genipin, 
where they reported the formation of very stable hydrogels, whose 
presence of genipin increased the hydrophilicity of chitosan. In 
addition, the results showed that secondary chemical interactions 
are formed via the reaction of genipin’s ester group with chitosan’s 
amine groups, yielding the hydrogel’s 3-dimensional structure [7]. 
Chemically crosslinked chitosan hydrogels have also been prepared 
without the addition of an external crosslinking agent. In fact, 
reacting chitosan in the solid state with nitrogen oxide gases 
generated in situ produced chitosan derivatives with aldehyde 
groups in their structures, which could self-crosslink through Shiff’s 
base reaction between the aldehyde and the amine groups.  
These interchain reactions produced semi-solid hydrogels by simply 
dispersing this aldehyde-functionalized chitosan in water at proper 
concentration [49]. In this method, chitosan undergoes deaminative 
cleavage of the 1,4-glycosidic bond, producing 2,5-anhydro-D-
mannose as the reducing end, which contains an aldehyde group. 
The latter can be further converted to 5-hydroxymethyl-2-furfural 
(HMF) at low pH (fig. 3). 
 
 
Fig. 3: Methods for obtaining aldehyde-functionalized chitosan: the reaction of chitosan (A) with periodate ions producing dialdehyde 
derivatives (B) and with nitrous acid-producing derivatives (C) containing 2,5-anhydro-D-mannose (circled) at the reducing end. The 
latter can be cleaved at low pH and converted to 5-hydroxymethyl-2-furfural (HMF) (D). Source: Author’s own design 
 
Chitosan hydrogels as drug delivery systems  
The physical properties of chitosan hydrogels have enabled their use 
in drug delivery applications. The ability of molecules of different 
sizes to diffuse into (drug loading) and out of (drug release) chitosan 
hydrogels allows the possible use of dry or swollen polymeric 
networks as drug delivery systems [38]. In addition, their highly 
porous structure can be modulated by the polymer concentration as 
well as by the degree of crosslinking, which in turn can influence the 
affinity of the hydrogels for the aqueous environment. This can 
modify the swelling extent of the network and therefore, have a 
direct impact on the drug release [22].  
Hydrogels are usually glassy in their dehydrated state and therefore, 
drug release generally involves absorption of water and desorption 
of drug through a swelling-controlled mechanism. When a 
dehydrated hydrogel is placed in contact with water or any other 
medium, it allows solvent penetration into the free spaces or pores 
distributed in the matrix. The presence of solvent inside the 
hydrogel causes the development of internal stresses that are 
accommodated by an increase in the end-to-end distance of polymer 
chains, which is seen macroscopically as swelling [38]. In general, 
chitosan swelling process is controlled by the free amine groups, 
which protonate at low pH (<chitosan’s pKa) and leads to an increase 
in the osmotic pressure inside the hydrogel due to the NH3+-
NH3+
According to Hoare and Kohane [22], the crosslinking density of the 
hydrogels can be controlled by the amount of crosslinker added, 
where higher crosslinking densities result in hydrogels with smaller 
mesh sizes, thereby reducing the release rate of entrapped drugs. 
The same authors also stated that the high water content of most 
hydrogels typically results in the relatively rapid release of drugs 
from the matrix, particularly in the case of hydrophilic drugs. Thus, 
two strategies have been used to retard the release of drugs from 
chitosan hydrogels:  
electrostatic repulsion. The difference between the osmotic 
pressure inside and outside the solution of the network is balanced 
by the swelling of the hydrogel, thereby controlling the drug release 
[48]. Thus, factors that influence the extent of chitosan swelling, 
which can affect the drug release rate, include its degree of 
ionization, crosslinking density and hydrophilicity, as well as the 
properties of the swelling medium (pH and ionic strength) [38].  
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1- Enhancing the interactions between the drug and the hydrogel 
matrix, where the drug can interact with the hydrogel matrix 
through both physical and chemical means. Thus, charge 
interactions between protonated amine groups and negatively 
charged drugs have frequently been employed to delay drug release.  
2- Increasing the diffusive barrier to drug release from the 
hydrogel, which can be achieved by increasing the degree of 
crosslinking of the hydrogel [22]. 
Mechanisms of drug release from chitosan hydrogels 
The release of a molecule from a chitosan hydrogel network can 
follow three mechanisms, according to the rate-limiting step for 




The diffusion-controlled mechanism is the most widely applicable 
one for describing drug release from chitosan hydrogels as it occurs 
when the hydrogel rapidly swell in an aqueous medium. On the 
other hand, swelling-controlled release occurs when the diffusion of 
the molecule is faster than the hydrogel swelling, whereas 
chemically-controlled release involves molecule released by 
reactions occurring within the hydrogel, such as cleavage of polymer 
chains via hydrolytic/enzymatic degradation [36]. In fact, fibroblast 
growth factor (FGF)-2 as well the antitumor agent Paclitaxel have 
been incorporated into a photo cross linkable chitosan hydrogel, 
where both agents were gradually released as the hydrogel was 
biodegraded in vivo [50]. 
As aforementioned, diffusion-controlled release through the 
hydrogel mesh is still the primary mechanism of release of most 
drugs from chitosan hydrogels. Due to its high swelling capacity, 
chitosan hydrogels can swell and uptake large quantities of water, 
which can lead to typical mesh sizes ranging from 5 to 100 nm in 
their swollen state. Since they are much larger than most small drug 
molecules, the diffusion of such drugs is not significantly retarded. 
However, due to their hydrodynamic radii, macromolecules like 
protein and peptides might have a greater chance of being released 
in a sustained manner. Therefore, the diffusion of molecules from a 
chitosan hydrogel matrix becomes slower as the mesh size 
approaches the size of the solute [36].  
In fact, Azevedo and Kumar [51] showed that the release of drugs 
from a self-gelling aldehyde functionalized chitosan hydrogel 
depended on the size of the drug molecule, where the release of 
metronidazole (Mw 171 Da) was much faster compared to the 
release of larger molecules such as FITC-dextran (Mw 40000 Da) 
and bovine serum albumin (Mw 66000 Da). In addition, a delayed 
release of amino acids from chitosan hydrogels has been reported, 
where a maximum of 6% of cumulative release was achieved over 
24 h. The authors hypothesized that besides the large molecular 
weight of such difusants, a polyelectrolyte complex between the 
positively charged chitosan and the negatively charged amino acids 
might have contributed to the strong retention of the latter in the 
chitosan hydrogel matrix [3].  
Besides the molecular weight of the drug, the method used to load it 
into chitosan hydrogel directly influences the rate and extent of drug 
release, where the direct addition of drugs to chitosan hydrogels has 
been the most used approach for drug incorporation [2]. 
Methods used to load drugs into chitosan hydrogels 
Loading drugs into chitosan hydrogels can be performed during the 
hydrogel formation, where the drug is added in the chitosan solution 
prior to adding the crosslinking agent. In this case, the drug can be 
either dissolved or suspended in the chitosan solution. Alternatively, 
the drug can be loaded by diffusing through the pores of the 
hydrogel after crosslinking. In this method, the hydrogel is allowed 
to swell to equilibrium in a drug solution, where the drug diffuses 
into the hydrogel matrix. Although these two methods represent the 
easiest ways to load drugs into hydrogels, the release typically 
shows a rapid burst during the initial hydrogel swelling, which can 
lead to losses from 10-25% to 70% of the initial drug load depending 
on the crosslinking density[37]. Chlorhexidine gluconate has been 
loaded into chitosan hydrogels for oral mucosal release. The amount 
of chlorhexidine gluconate released from the hydrogels was a 
function of crosslinking density, where chitosan hydrogels 
crosslinked with tripolyphosphate released the drug slower than 
those prepared without the crosslinking agent. The authors 
attributed this difference to a change in porosity of the hydrogels 
after cross-linking [52]. On the other hand, paclitaxel has been 
delivered from a thermo sensitive chitosan-based hydrogel for over 
a period of 1 mo [53]. 
The use of chitosan hydrogels as scaffolds for tissue 
engineering  
The options for treatment of a failed or injured organ/tissue include 
repair, replacement with a synthetic or natural substitute, or 
regeneration. Tissue repair or replacement with a synthetic 
substitute is limited to those situations where surgical methods and 
implants have not achieved success. Although implants have been a 
reasonably successful option, tissue engineering holds out great 
promise for regeneration of the failed tissue [19]. Tissue engineering 
is the development and manipulation of laboratory-grown cells and 
tissues that would replace or support the function of defective or 
injured parts of the body. Therefore, tissue-engineering technology 
has been developed to construct artificial tissues that can mimic the 
natural ones by combining modulated cells with different types of 
scaffolding materials [38].  
The wide array of tissue engineering applications is fonded upon the 
use of polymer scaffolds, which serve to support, reinforce and 
organize the regenerating tissue [26]. Hydrogels resemble living 
tissues closely in their physical properties because of their relatively 
high water content as well as their soft and rubbery consistency [38, 
43]. In addition, hydrogels derived from naturally occurring 
polymers such as chitosan, mimic many features of extracellular 
matrix and therefore have the potential to direct the migration, 
growth and organization of cells during tissue formation [54].  
For these reasons, hydrogels based on natural polymers have 
become attractive for tissue engineering applications as scaffolds for 
repairing and regenerating a wide variety of tissues and organs [4, 
19]. Due to their low immunogenic activity, controlled 
biodegradability and porous structure, chitosan scaffolds are 
promising materials for the design of tissue-engineered systems 
[33]. Table 2 lists the optimal properties of hydrogels that are 
required to be successfully used as drug carriers and scaffolds for 
tissue engineering.  
 
Table 2: Required properties of hydrogels for applications as 
drug carriers and scaffolds for tissue engineering 
Drug carriers Scaffolds for tissue engineering 
Biocompatible Biocompatible 
Mucoadhesive Biodegradable 
Mechanically stable Mechanically stable 
High drug loading efficiency Highly porous 
Control the drug release Interconnected pores 
 Source: Author’s own design 
 
Preparation of porous chitosan scaffolds  
The presence of interconnecting pores as well the optimal pore 
size and shape are among the conditions in which a synthetic 
scaffold for tissue engineering has to fulfill. The presence of 
interconnecting pores is important to ensure the supply of the 
cells with nutrients and to favor tissue integration and 
vascularization. In addition, the pore size and shape are 
important for cell infiltration and tissue regeneration [19]. Thus, 
the high porosity of hydrogels permits loading of cells and 
depending on the pore size and interconnectivity it can lead to 
cell differentiation and eventually tissue formation [22].  
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The most frequently used method to prepare porous scaffolds is 
through lyophilization of polymeric solutions or gels (hydrogels), 
where the water inside the matrix is frozen and then sublimated, 
which creates pores [55]. For instance, chitosan hydrogels crosslinked 
with glutaraldehyde or oxidized dextran have been investigated as 
potential scaffolds for cartilage regeneration, where the scaffolds were 
prepared after lyophilizing the previously frozen crosslinked chitosan 
hydrogel, yielding an interconnected porous structure with diameters 
ranging between 120-350 µm [19]. However, considering that the 
chitosan scaffold will be degraded by lysozyme, glutaraldehyde will be 
prone to leach out into the body [54].  
On the other hand, chitosan hydrogels formed by polyelectrolyte 
complex have been used as scaffolds in cell culture and enzyme 
immobilization. Since no potentially toxic cross linkers were used to 
prepare these hydrogels, they represent a better medium for cell 
culture. However, their poor mechanical properties could not 
prevent their dissolution and the release of the incorporated cells 
[18]. In addition, Madihally and Matthew [26] prepared chitosan 
porous tubular scaffolds without any external crosslinker by just 
lyophilizing a 2% chitosan solution in annular molds. The obtained 
tubular scaffolds, which were stabilized in either NaOH (0.1 N) or in 
ethanol series, showed a high level of porosity and the presence of 
interconnected pores. However, the fact that no crosslinking took 
place during the preparation of these scaffolds, poor physical and 
mechanical stability of such constructs might become a concern 
during the washing process and even during the cell seeding/ 
expansion in an aqueous medium. In fact, these authors reported 
that the NaOH-treated scaffolds exhibited shrinkage and distortion, 
in addition to an extremely low tensile strength [26]. Chitosan 
scaffolds have also been prepared from chitosan-poly (vinyl alcohol) 
hydrogels where crosslinking took place between both polymers as 
well as through the use of glutaraldehyde. The results showed that 
the mechanical properties of the scaffolds strongly depended on the 
amount of glutaraldehyde (degree of crosslinking) as well as on the 
poly (vinyl alcohol)/chitosan ratio [56]. 
Azevedo and Kumar (2012) prepared a highly porous scaffold with 
interconnected pores (fig. 4) out of an aldehyde-functionalized 
chitosan hydrogel, which could self-crosslink and gellify in situ 
without the addition of any external crosslinking agent, favoring the 
biocompatibility of such constructs. The scaffolds were prepared 
through the lyophilization method, where it could absorb more than 
400 % of its weight in water [51]. 
 
 
Fig. 4: SEM pictures of semi-solid hydrogels prepared from a self-gelling aldehyde functionalized chitosan. The 4 pictures were taken from 
the same sample, but at different spots. Source: Author’s own results 
 
The porosity and pore size of chitosan scaffolds have shown to be 
dependent on the concentration of chitosan solution. Hsieh et al. 
[57] showed that the pore size and porosity of chitosan scaffolds 
were reduced along with the increase in the concentration of 
chitosan solutions from 1 to 3%. Madihally and Matthew [26] also 
demonstrated that the pore connectivity was influenced by the 
concentration of the chitosan solution, where higher concentrations 
produced lower pore connectivity. According to Harley et al. [58], 
ideal porous tubular scaffolds should display a gradient in porosity 
and pore size along the tube radius, as well as a porous lumen and a 
cell-impermeable outer surface. In addition, Song et al. [59] showed 
that the efficiency of smooth muscle cells (SMC) seeding in porous 
tubular poly(trimethylene carbonate) (PTMC) scaffolds increased 
from less than 10% to 43% after coating its external surface with a 
PTMC layer while still keeping the inner pore structure. Generally, 
SMC are seeded by perfusion of a cell suspension from the lumen 
through the wall of a tubular scaffold and the absence of pores on 
the outer surface leads to higher cell retentions.  
Moreover, in order to have a better diffusion of nutrients and waste 
products, as well a more efficient cell proliferation, a more open and 
interconected pore structure is preferred [59]. Zeltinger et al. [60] 
showed that vascular smooth muscle cells (SMC) displayed 
equivalent proliferation and matrix deposition in scaffolds with pore 
sizes ranging from 63 to 150 µm. Similarly, Park et al. [61] showed 
that SMC proliferation was the highest in a poly (L-lactide-co-ε-
caprolactone) (PLCL) scaffold with 50-100 µm pore size. 
CONCLUSION 
Chitosan is a versatile material with many biological properties, 
where most of these properties is due to its amine groups that can 
be protonated when in solution. Due to its ability to protonate, 
chitosan hydrogels can swell and increase more than 100% of its 
volume in water, which contributes to its high porosity. In fact, 
because of the high swelling capacity of chitosan hydrogels, the 
release of drugs is usually through diffusion-controlled mechanism, 
where the release rate can be influenced by the molecular weight of 
the drug as well as by the degree of crosslinking of the hydrogel. In 
addition, very porous constructs can be obtained through the 
lyophilization of chitosan hydrogels, which can be used as scaffolds 
for tissue engineering. Finally, the biocompatibility, biodegradabilty 
and non-toxicity aspects of these hydrogels make them even more 
attractive for drug delivery and tissue engineering applications. 
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